Table 4.

Topics of Educational Interest Among Hematology/Oncology Healthcare Providers

	Hematology/Oncology Physicians			Hematology/Oncology Nurses
Please indicate which of the following CME topics would be important in helping you to better manage your patients who are at risk for CINV.	Strongly Agree, %	Agree, %	Disagree, %	Strongly Agree, %	Agree, %	Disagree, %
Adhere/interpret the CINV guidelines	49	48	3	47	50	2
Communicate with patients about CINV	40	54	6	55	41	4
Differentiate between CINV therapies	45	51	4	55	44	1
Integrate novel therapies for the prevention and treatment of CINV	57	41	2	59	39	2
Keep up to date on emerging clinical data in CINV	50	48	3	58	42	0
Options for managing radiation- and opioid-induced CINV	37	57	6	48	48	4
Prevent/manage breakthrough nausea and vomiting	55	41	4	62	36	2
Prevent/manage CINV in patients undergoing bone marrow transplant	28	50	22	45	40	15
Prevent/manage CINV when administering multiday chemotherapy	54	39	7	59	40	1
Prevent/manage nausea specifically	40	56	4	54	44	2
Understand barriers to adherence with antiemetic guidelines	34	56	10	50	46	5
Understand the consequences of untreated/uncontrolled CINV for the patient (and caregivers)	38	53	9	49	48	3
Understand the pharmacoeconomic consequences of untreated/uncontrolled CINV	37	50	13	49	46	5
Overcoming challenging CINV patient scenarios	35	58	6	42	54	4
Personalizing CINV treatment	44	53	3	51	48	2
Selecting the most effective therapies to prevent CINV	54	45	1	53	47	1
Stratifying patients according to their risk for CINV	39	57	3	42	53	5
Treating refractory CINV	57	40	3	51	46	3
Understanding the mechanism of CINV therapies	36	59	4	43	53	4
Understanding the patient-related factors that increase the risk of CINV	41	57	3	47	53	4
Understanding the pathophysiology of CINV	38	55	8	46	48	6
Understanding the side-effect profile of CINV therapies	39	55	7	46	51	3
Utilizing standing orders for CINV	25	59	15	41	53	6
Working as a multidisciplinary team to overcome CINV	33	52	15	46	50	4